Clik here to view.
Advancing women’s health research
By: Pamela E. Scott, Ph.D. Career inspiration can come from many sources. My inspiration came from a broken ankle. In the winter of 1999, I broke several bones and had three surgeries to repair my...
View ArticleClik here to view.
C.R. Bard closes $181m Liberator Medical buy
C.R. Bard (NYSE:BCR) said yesterday that it closed the $181 million acquisition of Liberator Medical (NYSE:LBMH), a direct-to-consumer distributor of durable medical equipment. The deal called for...
View ArticleClik here to view.
UPDATE: Philips forced to spike Lumileds deal on U.S. security concerns
Updated with new information on the proposed sale. (Reuters) — Royal Philips‘s (NYSE:PHG) plan to shed its lighting businesses suffered a setback on Friday when a $3.3 billion deal to offload the...
View ArticleClik here to view.
InspireMD CEO Milinazzo, CTO Bar to bow out | Personnel Moves
InspireMD (OTC:NSPR) said today that it’s looking for a replacement for CEO Alan Milinazzo as it looks to drill down on the largest markets for its CGuard and MGuard stents, which are designed to help...
View ArticleClik here to view.
Sales and profits slide for GE Healthcare
General Electric (NYSE:GE) said today that sales and profits in its GE Healthcare division slid for both the 4th quarter and full-year 2015, as the industrial conglomerate’s overall sales missed...
View ArticleClik here to view.
Intuitive Surgical CEO Guthart unfazed by upcoming competition
Gary Guthart, the longtime CEO of robot-assisted surgery pioneer Intuitive Surgical (NSDQ:ISRG), said yesterday that he’s confident Intuitive will be able to compete as smaller rivals begin hitting the...
View ArticleClik here to view.
FDA proposes to require PMAs for cranial electrotherapy stimulators for...
The FDA is proposing to require manufacturers of cranial electrotherapy stimulators to submit pre-market approval applications if their devices are intended to treat depression. The federal safety...
View ArticleClik here to view.
Cardiovascular Systems tumbles on Q2 misses
Cardiovascular Systems shares plummeted after releasing significant misses for its FY2016 Q2 earnings, dropping over 30% in mid-day trading. St. Paul, Minn.-based Cardiovascular Systems reported...
View ArticleClik here to view.
K2M wins CE Mark for Rhine cervical disc
K2M (NSDQ:KTWO) said yesterday it won CE Mark approval in the European Union for its Rhine cervical disc system designed to treat degenerative disc disease. The Leesburg, Va.-based company said the...
View ArticleClik here to view.
Advanced Medical Isotope hires IR firm Circadian Group
Advaned Medical Isotope Corp said Wednesday it hired medical device, pharma and biotech-focused investor relations firm Circadian Group. Newly-retained Circadian group will focus on presenting AMIC’s...
View ArticleClik here to view.
MassDevice.com +3 | The top 3 medtech stories for January 22, 2016
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...
View ArticleClik here to view.
FDA clears next-gen Pelvalon incontinence device
Pelvalon said yesterday it won FDA 510(k) for its next-generation Eclipse incontinence device designed for women suffering loss of bowel control. Sunnyvale, Calif.-based Pelvalon’s Eclipse is designed...
View ArticleClik here to view.
ResMed jumps on Q2 earnings beat
ResMed (NYSE:RMD) saw shares jump after releasing Q2 earnings that topped the street in revenue and earnings. The San Diego, Calif.-based reported profits of $90.5 million, or 65¢ per share, on sales...
View ArticleClik here to view.
Vascular Solutions droops on Q4, FY2015 earnings
Vascular Solutions (NSDQ:VASC) shares drooped over 10% after releasing a mixed bag of Q4 and its 2015 fiscal year earnings, beating the street for quarterly EPS and revenue, but missing for FY2015....
View ArticleClik here to view.
Mercator MedSystems launches dual-therapy BTK Bullfrog device trial
Mercator MedSystems said yesterday it enrolled the 1st patient in its Limbo-PTA clinical trial aiming to examine the use of the company’s Bullfrog micro-infusion device delivering anti-inflammatory...
View ArticleClik here to view.
FDA: St. Jude Medical’s Optisure recall is Class I
The FDA termed a recall by St. Jude Medical (NYSE:STJ) of a small number of its Optisure defibrillator leads as Class I, denoting the risk of serious injury or death. Little Canada, Minn.-based St....
View ArticleClik here to view.
Relieving pain … with light?
Consider this scenario: A patient is home recovering from knee surgery to repair an ACL tear. Her pain medications are wearing off, and the surgical cuts are starting to throb. Reaching over to the...
View ArticleClik here to view.
GW Plastics’ “School of Tech” class designs new product
In response to a growing regional and national skilled labor shortage, GW Plastics is leading the way in workforce training, career development, and community educational outreach through their...
View ArticleClik here to view.
Pavmed scales back IPO to $6m
Pavmed last week dramatically trimmed its pending initial public offering, saying it plans to float 1.2 million shares at $5 apiece for gross proceeds of $6 million. That’s a far cry from the $23...
View ArticleClik here to view.
Court approves Baxter’s $43m settlement deal in shareholders suit
A federal judge last week approved the $42.5 million settlement of a class-action securities lawsuit brought against Baxter (NYSE:BAX) over the recall of its Colleague infusion pump and a too-rosy...
View Article